Partner
Explore A Novel Platform
At Genlumina, we’re on a mission to redefine cancer treatment with light. As we work to establish a new standard in cancer care over the coming decade, we’re inviting visionary partners to join us. Discover how you can be part of this journey.
Medical Specialists – Key Opinion Leaders
Together, we proof it is clinically relevant in your area of expertise that a cell precision treatment is offering hope and a new perspective for patients.
We provide proof-of-principle studies, grant support, and co-publication opportunities, forming a foundation for therapies that deliver both precision and effectiveness.
Targeting Therapeutic Partners
Together, we link our drug as payload to existing targeting mechanisms (Antibody Drug Conjugates/Peptide Drug Conjugates) that target specific types of cancer and can be reached with light.
We create an oppurtunity to join forces with researchers in the field of targeting therapeutics. This way a valuable biomarker becomes an effective therapy too.
MedTech Imaging Companies
Together, we combine our light-activated drug with your (extended) imaging systems, allowing hospitals and clinics to deliver precision treatments without requiring extensive equipment changes.
We provide a valuable enhancement for imaging platforms, helping healthcare providers expand their treatment capabilities with minimal disruption.
VC / Pharmaceutical Companies
Together, we can advance GenLumina’s technology to clinical trials, leveraging our safety and efficacy to develop a treatment that complements and enhances existing oncology treatments.
we support pharmaceutical partners through regulatory milestones, enabling an innovative addition to your oncology pipeline that has the potential to create significant patient impact.
You can count on us for using our drug to push the boundaries of what is possible in precision oncology.